The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

10 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
27
Potent Body Weight-Lowering Effect of a Neuromedin U Receptor 2-selective PEGylated Peptide.EBI
Takeda Pharmaceutical
9
Design, synthesis and biological activity of flavonoid derivatives as selective agonists for neuromedin U 2 receptor.EBI
East China Normal University
2
Discovery of potent hexapeptide agonists to human neuromedin u receptor 1 and identification of their serum metabolites.EBI
Tokyo University of Pharmacy and Life Sciences
6
Discovery of selective hexapeptide agonists to human neuromedin U receptors types 1 and 2.EBI
Tokyo University of Pharmacy and Life Sciences
3
Design and synthesis of peptidic partial agonists of human neuromedin U receptor 1 with enhanced serum stability.EBI
Tokyo University of Pharmacy and Life Sciences
2
A chemically stable peptide agonist to neuromedin U receptor type 2.EBI
Tokyo University of Pharmacy and Life Sciences
17
Small lipidated anti-obesity compounds derived from neuromedin U.EBI
University of California At Los Angeles
13
Synthesis and EBI
Vrije Universiteit Brussel
42
Development of potent and proteolytically stable human neuromedin U receptor agonists.EBI
Vrije Universiteit Brussel
20
A potent neuromedin U receptor 2-selective alkylated peptide.EBI
Takeda Pharmaceutical